Transgenic mice expressing mutations in tau have yielded essential discoveries for Alzheimer’s disease. One of the most commonly used tau mouse models is the tet-off Tg(tauP301L)4510 model that expresses P301L human tau driven by the calcium-calmodulin kinase IIα (CaMKIIα) promoter system. Tau expression in this model is regulatable, allowing for suppression of mutant tau expression until adulthood and prevention of possible developmental alterations resulting from P301L tau expression during development. Here, we compared the effect and sample sizes needed for three learning and memory tasks in mice with adult-onset P301L tau expression. Our findings indicate that the Incremental Repeated Acquisition (IRA) and trace fear conditioning tasks...
Alzheimer\u27s disease is increasing to epidemic levels with an estimated 36 million people affected...
The neuropathological hallmark shared between Alzheimer's disease (AD) and familial frontotemporal d...
can lead to early onset of familial AD (FAD). Although mutations in the tau encoding gene MAPT lead...
Transgenic mice expressing mutations in tau have yielded essential discoveries for Alzheimer’s disea...
The greatest risk factor for developing Alzheimer’s disease (AD) is increasing age. Understanding th...
Neuropathological hallmarks of Alzheimer’s disease (AD) include brain β-amyloid deposition and neuro...
Introduction: Tau is a microtubule-associated binding protein implicated in neurodegenerative tauopa...
Tauopathies are neurodegenerative disorders characterized by the accumulation of abnormal tau protei...
The microtubule binding protein tau is implicated in neurodegenerative tauopathies, including fronto...
Tauopathies are neurodegenerative disorders characterized by the accumulation of abnormal tau protei...
Tau is a microtubule-associated binding protein implicated in neurodegenerative tauopathies, includi...
Neurofibrillary lesions of abnormal Tau are hallmarks of Alzheimer disease and frontotemporal dement...
Tau has been implicated in the organization, stabilization, and dynamics of microtubules. In Alzheim...
Alzheimer’s disease is increasing to epidemic levels with an estimated 36 million people affected wo...
Alzheimer's disease (AD), the most common cause of dementia afflicting 24 million people worldwide, ...
Alzheimer\u27s disease is increasing to epidemic levels with an estimated 36 million people affected...
The neuropathological hallmark shared between Alzheimer's disease (AD) and familial frontotemporal d...
can lead to early onset of familial AD (FAD). Although mutations in the tau encoding gene MAPT lead...
Transgenic mice expressing mutations in tau have yielded essential discoveries for Alzheimer’s disea...
The greatest risk factor for developing Alzheimer’s disease (AD) is increasing age. Understanding th...
Neuropathological hallmarks of Alzheimer’s disease (AD) include brain β-amyloid deposition and neuro...
Introduction: Tau is a microtubule-associated binding protein implicated in neurodegenerative tauopa...
Tauopathies are neurodegenerative disorders characterized by the accumulation of abnormal tau protei...
The microtubule binding protein tau is implicated in neurodegenerative tauopathies, including fronto...
Tauopathies are neurodegenerative disorders characterized by the accumulation of abnormal tau protei...
Tau is a microtubule-associated binding protein implicated in neurodegenerative tauopathies, includi...
Neurofibrillary lesions of abnormal Tau are hallmarks of Alzheimer disease and frontotemporal dement...
Tau has been implicated in the organization, stabilization, and dynamics of microtubules. In Alzheim...
Alzheimer’s disease is increasing to epidemic levels with an estimated 36 million people affected wo...
Alzheimer's disease (AD), the most common cause of dementia afflicting 24 million people worldwide, ...
Alzheimer\u27s disease is increasing to epidemic levels with an estimated 36 million people affected...
The neuropathological hallmark shared between Alzheimer's disease (AD) and familial frontotemporal d...
can lead to early onset of familial AD (FAD). Although mutations in the tau encoding gene MAPT lead...